Vijaya Diagnostic Centre Expands Services And Declares Dividend

Vijaya Diagnostic Centre Ltd, one of India’s leading diagnostic chains, announced its March quarter results alongside a strategic acquisition. The purchase of MRI, EEG, and NCV services from Medinova Millennium MRI enhances its service offerings and reinforces its leadership in advanced diagnostic solutions.

Financial Performance

Revenue from operations stood at ₹2.19 billion, supported by strong patient volumes and service expansion. Net profit reached ₹479.3 million, reflecting operational efficiency and profitability.

Dividend Declaration

The board recommended a final dividend of ₹2 per share, underscoring confidence in the company’s financial strength and commitment to shareholder value.

Strategic Outlook

Analysts believe the acquisition will strengthen Vijaya’s competitive edge in the healthcare diagnostics sector. The company’s focus on expanding infrastructure, enhancing service quality, and leveraging technology is expected to drive long-term growth.

Key highlights

• Acquisition of MRI, EEG, and NCV services from Medinova Millennium MRI
• Consolidated revenue at ₹2.19 billion in Q4
• Net profit reported at ₹479.3 million
• Final dividend of ₹2 per share recommended
• Focus on expanding advanced diagnostic services

Sources: Company filings, Reuters updates, market reports